BridgeBio

Recent Finacing

Debt

Recent Raise

$750M

BridgeBio Pharma discovers, develops, and advances genetically targeted therapeutics across multiple therapeutic areas using a centralized R&D platform and asset-specific subsidiary structure, with programs from preclinical to late-stage.

Founded 2015

California, United States

251-500

Publicly Traded

bridgebio.com

Highlights

Focus Areas

Biotechnology

Health Care

Life Science

Medical

Pharmaceutical

Recent Investors

Financials

$1.2B

Total Raised

3

Funding rounds

9

Investors

Team

Upgrade to view the team

See the team members at BridgeBio.